DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

International Collaborative Ovarian Neoplasm Group.
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial.

Lancet 2002;
360: 505-15

Download Bibliographical Data

Access:
Access: